Allergan Plc (AGN)

170.97
0.81 0.48
NYSE : Health Technology
Prev Close 170.16
Open 170.30
Day Low/High 170.06 / 171.23
52 Wk Low/High 114.27 / 192.69
Volume 1.81M
Avg Volume 3.47M
Exchange NYSE
Shares Outstanding 328.10M
Market Cap 55.43B
EPS -15.30
P/E Ratio N/A
Div & Yield 2.96 (1.74%)

Latest News

Allergan Shareholders Approve Proposed Acquisition By AbbVie

Allergan Shareholders Approve Proposed Acquisition By AbbVie

DUBLIN, Oct. 14, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc...

Allergan And Molecular Partners Present Late-Breaking Data From Phase 3 Studies Of Investigational Abicipar Pegol In Neovascular Wet Age-Related Macular Degeneration

Allergan And Molecular Partners Present Late-Breaking Data From Phase 3 Studies Of Investigational Abicipar Pegol In Neovascular Wet Age-Related Macular Degeneration

- Two-year results from CEDAR and SEQUOIA demonstrate that vision gains observed after one year with every 8-week and every 12-week dosing were maintained in the second year -

Thomas Wellauer To Join Aegon's Supervisory Board; Robert Dineen Steps Down

Thomas Wellauer To Join Aegon's Supervisory Board; Robert Dineen Steps Down

Aegon announces that Thomas Wellauer will be nominated for appointment to the Supervisory Board for a four-year term.

On World Sight Day, Allergan Launches National Campaign To Raise Awareness Of The Toll Glaucoma Takes On Everyday Living

On World Sight Day, Allergan Launches National Campaign To Raise Awareness Of The Toll Glaucoma Takes On Everyday Living

-- Allergan launches interactive website, MyGlaucoma.com, to shed light on the burden of the disease, provide patient and caregiver perspectives and resources to help --

On World Sight Day, Allergan Launches National Campaign To Raise Awareness Of The Toll Glaucoma Takes On Everyday Living

On World Sight Day, Allergan Launches National Campaign To Raise Awareness Of The Toll Glaucoma Takes On Everyday Living

-- Allergan launches interactive website, MyGlaucoma.com, to shed light on the burden of the disease, provide patient and caregiver perspectives and resources to help -

Adding to AbbVie

We like AbbVie down here because we think the Allergan deal puts AbbVie's back in control of its own destiny.

Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA™ Lubricant Eye Drop Product Line

Allergan Expands REFRESH® Portfolio With New REFRESH® RELIEVA™ Lubricant Eye Drop Product Line

- A Trifecta of Relief Formulated with HydroCell™ Technology Offers New Artificial Tear Options for Patients Suffering from Eye Dryness -

INVESTOR ALERT: Monteverde & Associates PC Announces An Investigation Of The Following Merger

INVESTOR ALERT: Monteverde & Associates PC Announces An Investigation Of The Following Merger

NEW YORK, Oct. 3, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: Chardan Heathcare Acquisition...

Allergan To Showcase Late-Stage Data In Age-Related Macular Degeneration And Glaucoma At American Academy Of Ophthalmology Annual Meeting

Allergan To Showcase Late-Stage Data In Age-Related Macular Degeneration And Glaucoma At American Academy Of Ophthalmology Annual Meeting

- Presentations include a late-breaking Abicipar abstract and topline Phase 3 results of Bimatoprost SR -

Video: Jim's Daily Rundown for Wednesday

Jim discusses Disney and the Disney+, Goldman Sachs, Johnson & Johnson, PepsiCo ahead of Thursday's earnings, and much more!

Endo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares Rise

Endo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares Rise

The Wall Street Journal reports the companies are considering participating in the bankruptcy proceedings of Purdue Pharma.

Allergan And AbbVie Receive Second Request From Federal Trade Commission On Pending Transaction

Allergan And AbbVie Receive Second Request From Federal Trade Commission On Pending Transaction

DUBLIN, Sept. 27, 2019 /PRNewswire/ --  NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc...

AbbVie And Allergan Receive Second Request From Federal Trade Commission On Pending Transaction

AbbVie And Allergan Receive Second Request From Federal Trade Commission On Pending Transaction

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Aegon Establishes International Division And Intends To Appoint Maarten Edixhoven To Its Management Board

Aegon Establishes International Division And Intends To Appoint Maarten Edixhoven To Its Management Board

Aegon will bring together its activities in Southern and Eastern Europe and Asia under Aegon International.

Don't Wait for China: Cramer's 'Mad Money' Recap (Friday 9/20/19)

Don't Wait for China: Cramer's 'Mad Money' Recap (Friday 9/20/19)

Jim Cramer says it's going to take longer than most people think to reach a trade deal with China. He's got your game plan for next week.

Aegon Announces Purchase Of Shares To Neutralize 2019 Interim Stock Dividend

Aegon Announces Purchase Of Shares To Neutralize 2019 Interim Stock Dividend

Shareholders were given the opportunity to choose between receiving the 2019 interim dividend of EUR 0.

Announcement Under The Irish Takeover Rules: Relevant Securities In Issue - September 17, 2019

Announcement Under The Irish Takeover Rules: Relevant Securities In Issue - September 17, 2019

DUBLIN, Sept. 17, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION In accordance...

Allergan Announces Commencement Of Mailing Of Proxy Statement

Allergan Announces Commencement Of Mailing Of Proxy Statement

DUBLIN, Sept. 17, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc...

Broadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must Know

Broadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must Know

U.S. stock futures rise as investors assess signs of a breakthrough in U.S.-China trade talks; Broadcom falls after saying chip demand has 'bottomed out'; WeWork will list its shares on the Nasdaq; Cloudflare's IPO is priced at $15 a share.

AbbVie Stock Rises After UBS Upgrades To Buy

AbbVie Stock Rises After UBS Upgrades To Buy

The $79 price target is a 14% upside to Wednesday's closing price.

Allergan Shareholder Meetings Scheduled For October 14, 2019

Allergan Shareholder Meetings Scheduled For October 14, 2019

DUBLIN, Sept. 10, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Allergan plc...

Mike Holliday-Williams To Succeed Adrian Grace As CEO Of Aegon UK

Mike Holliday-Williams To Succeed Adrian Grace As CEO Of Aegon UK

Aegon today announces that Mike Holliday-Williams (1970, UK) will succeed Adrian Grace (1963, UK) as Chief Executive Officer of Aegon UK.

Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy

Mallinckrodt Plunges on Report It's Considering Filing for Bankruptcy

Shares of drugmaker Mallinckrodt plunge on a report the company is considering filing for bankruptcy as a way of dealing with its opioid-related legal liabilities.

Allergan Receives FDA Approval Of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula

Allergan Receives FDA Approval Of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula

DUBLIN, Sept. 3, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today it received U.

Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation

Allergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid Litigation

Allergan announces it has reached a settlement with two plaintiffs in Ohio in the multi-district federal litigation over opioids.

Allergan Announces Settlement With Two Ohio Plaintiffs In Federal Opioid Litigation

Allergan Announces Settlement With Two Ohio Plaintiffs In Federal Opioid Litigation

DUBLIN, Aug. 30, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the Company and its U.

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

These Drug Cos. Could Soon Feel Big Side Effects of Opioid Crisis

No company is safe from the litigation risk tied to the drug epidemic, but Johnson & Johnson may be one of the few guaranteed to survive.

TheStreet Quant Rating: C (Hold)